Consilient Health are pleased to announce the signing of a long-term, exclusive distribution agreement with bene-Arzneimittel GmbH, a Munich-based pharmaceutical company, to distribute elmiron® in the UK.
The UK deal was signed on 8th May 2018 and, further to that, a distribution agreement was signed on 26th November 2018 for Ireland for elmiron®.
elmiron® allows Consilient Health to expand in to the exciting urology segment and is in line with the company’s strategy of partnering with innovative companies to bring to market medicines that serve a clear unmet clinical need.
Code No: UK/ELM/0419/0026
Date of Preparation: April 2019